in zone I, and 1.1% of those in zone II. Five patients (9.8%) had difficult intubation, but no significant intra-or post-operative systemic complications were observed. Significant ocular complications included vitreous hemorrhage (2.9%), transient corneal edema (2.0%), and exudative retinal detachment (1.0%); all were resolved spontaneously after several weeks.
The findings of our study suggest that transpupillary diode laser photocoagulation under general anesthesia is an effective and safe procedure for treating type 1 ROP. Overall, 97.1% of treated eyes showed favorable structural outcome in short-term. However, this approach was less effective for zone I ROP than zone II; corroborating findings from previous studies. 4 Parvaresh et al. 5 used transscleral diode laser photocoagulation under topical anesthesia for treating ROP and found similar structural outcomes as the present study (96.1% vs. 97.1% anatomical success, respectively). The mean gestational age of treated neonates in our study was 29.0±1.9 weeks, similar to that reported by Parvaresh et al. 5 (29.2±2.2 weeks). The greatest gestational age for type 1 ROP recorded in these studies were 35 and 34 weeks, respectively. The greatest recorded birth weight was 2,000 grams in our study and 1,850 grams in Parvaresh et al. 5 Consequently, it is unlikely that in our region a neonate with gestational age >35 weeks and birth weight > 2,000 grams turns into type 1 ROP.
The major drawbacks of the present study include the retrospective nature, short follow-up period, and the absence of functional data due to the very young age of infants at the time of data collection. These limitations could be partially mitigated in future reports on medium-and long-term results of the same cohort. The strengths of the study comprise the uniformity in screening, treatment approach, and diversity of treated infants that were referred from the entire part of southern Iran.
